About: http://data.cimple.eu/news-article/4dae5bb4dbf35769bfc203e4632f3c7bb69314de55a7e06026a805db     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • Kyrgyzstan on Monday kicked off its coronavirus vaccination campaign using China's Sinopharm jab, as the West accuses Beijing and Moscow of using their vaccines as tools to win geopolitical clout. Russia and China both compete for economic and political influence in Central Asia, a majority Muslim former Soviet region, and also dominate the vaccine race there. Beijing this month donated 150,000 doses of its two-shot jab to Kyrgyzstan, enough to vaccinate 75,000 people, or just over one percent of the 6.5 million population. Energy-rich Kazakhstan rolled out vaccinations last month using Russia's Sputnik V vaccine but intends to introduce a nationally-produced jab at a later stage. In Kyrgyzstan, Health Minister Alymkadyr Beishenaliyev had the first shot of the campaign in front of reporters, sporting a vest and a smile after filling out a form for the vaccination and consulting with a doctor. "I feel fine," Beishenaliyev said after the shot, while admitting his fear of injections. The health minister said that medics would be first in line for vaccinations, followed by teachers, border guards, at-risk groups and people over 65 years old. Kyrgyzstan has also registered Russia's Sputnik, with Beishenaliyev saying that his country expected to receive up to half a million doses of that vaccine in May or June. The minister confirmed that Kyrgyzstan had suspended plans to secure doses of the AstraZeneca vaccine via the Covax programme, after several European countries paused rollout of the shot over blood clotting concerns before later resuming its use. "When we learn that deaths and clotting are not a result of the vaccine, we can begin (with AstraZeneca)," Beishenaliyev said. Both the World Health Organization and the European Union's drug regulator, the European Medicines Agency, say the AstraZeneca jab is safe to use and has no proven link to blood clots. Neighbouring Uzbekistan on Saturday received a million doses of a Chinese vaccine produced by the pharmaceutical company Anhui Zhifei Longcom Biopharmaceutical Co. The country of 34 million people, whose inoculation campaign will begin later this week, has said it expects to launch joint production of that Chinese vaccine this summer. Russia and China have rejected claims they are seeking to use coronavirus vaccines to project their influence around the world, and have accused Western countries of hoarding jabs to the detriment of poor nations. tol-cr/as/kjl
schema:headline
  • Kyrgyzstan begins vaccine rollout with China's Sinopharm
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software